Overview
- 11 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-04-09.
At a glance
Inspections
11
Form 483s
2
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 3 Apr 2025 – 9 Apr 2025 | Human Drugs | 483 | View 483 → |
| 7 Feb 2022 – 11 Feb 2022 | Human Drugs | Clean | |
| 28 May 2018 – 1 Jun 2018 | Human Drugs | Clean | |
| 6 Jul 2016 – 8 Jul 2016 | Human Drugs | Clean | |
| 18 May 2015 – 22 May 2015 | Medical Devices & Rad Health | Clean | |
| 23 May 2012 | Not recorded | Clean | |
| 12 Apr 2011 | Not recorded | Clean | |
| 18 May 2010 | Not recorded | Clean | |
| 9 Apr 2009 | Not recorded | 483 | On file |
| 25 Sep 2008 | Not recorded | Clean | |
| 20 Oct 2000 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
9 Apr 2025
FDCA 582(b)(4)
Systems in place to comply with verification requirements
Cited by Camerson E Moore
Investigators
FDA investigators tied to this site in the record.
Darla J Christopher2 insp.
Camerson E Moore1 insp.
Ariel Cruz Figueroa1 insp.
Kevin T Nguyen1 insp.
Timothy H Vo1 insp.
Shatina R Alridge1 insp.
Jason R Caballero1 insp.
Sonia R Peterson1 insp.
Uttaniti Limchumroon1 insp.
Margaret M Annes1 insp.
Jodi M Gatica1 insp.
Stephen D Brown1 insp.
Daniel J Lahar1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| FDCA 582(b)(4) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Kavis Pharma LLC's 2 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat